Evaluating Unfractionated Heparin Fixed Dosing Protocol and Establishing an Institutional Therapeutic Range for UFH in Hospital Setting in Jordan

Clinical and Applied Thrombosis/Hemostasis - United States
doi 10.1177/1076029612458722
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Evaluating Time in Therapeutic Range for Hemodialysis Patients Taking Warfarin

Clinical Nephrology
MedicineNephrology
2015English

Unfractionated Heparin for Hemodialysis: Still the Best Option

Seminars in Dialysis
Nephrology
2010English

Gentamicin Therapeutic Drug Monitoring: Importance in the Hospital Setting

West Indian Medical Journal
Medicine
2016English

Beyond Unfractionated Heparin and Warfarin: Current and Future Advances

Circulation
Cardiovascular MedicinePhysiologyCardiology
2007English

Heparin Bivalirudin in Acute Myocardial Infarction: Unfractionated Heparin Monotherapy Elevated to Primary Treatment in Contemporary Percutaneous Coronary Intervention

Open Cardiovascular Medicine Journal
Cardiovascular MedicineCardiology
2016English

Low Molecular Weight Heparin Versus Unfractionated Heparin for Thromboprophylaxis in Patients With Acute Atrial Fibrillation: A Randomized Control Trial

Acute Cardiac Care
Nuclear MedicineRadiologyEmergency MedicineCardiologyCardiovascular MedicineImaging
2011English

Pharmacogenetics of Warfarin in a Paediatric Population: Time in Therapeutic Range, Initial and Stable Dosing and Adverse Effects

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2014English

Unfractionated Heparin Monitoring With Activated Partial Thromboplastin Time

Pathology
Forensic MedicinePathology
2020English

Safety of Low-Molecular-Weight Heparin Compared to Unfractionated Heparin in Hemodialysis: A Systematic Review and Meta-Analysis

BMC Nephrology
Nephrology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy